A matter involving the termination of the license agreement granting Tasly exclusive rights to develop, manufacture and market C-REV in China, with the rights returned to the Company. This is the termination of a partnership tied to a specific product, partner and region, accompanied by the loss of upfront payments and milestone revenue under the agreement.